- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
APP Antibody reagents are used to study amyloid precursor protein, a widely expressed type I transmembrane glycoprotein with particularly important roles in nervous system research. APP undergoes extensive proteolytic processing that generates multiple soluble and membrane-associated products with distinct biological properties. Alternative splicing also produces several APP isoforms, contributing to the molecular diversity observed for this protein.
Amyloid precursor protein can be processed through amyloidogenic and non-amyloidogenic pathways. In the non-amyloidogenic pathway, alpha-secretase cleavage occurs within the amyloid beta sequence and prevents production of intact amyloid beta peptide. In the amyloidogenic pathway, sequential beta- and gamma-secretase cleavage generates amyloid beta peptides, including the extensively studied amyloid beta 40 and amyloid beta 42 forms. The processing, trafficking, and turnover of APP are therefore central areas of research into amyloid biology.
APP and its proteolytic products have been implicated in neuronal development, neurite outgrowth, cell adhesion, synaptic function, intracellular signaling, and responses to cellular stress. APP belongs to a protein family that also includes APLP1 and APLP2. Several APP isoforms additionally contain a Kunitz-type protease inhibitor domain and have historically been associated with names such as protease nexin-II and APPI.
Altered processing of APP is studied extensively in Alzheimer disease and related neurodegenerative disorders. Amyloid beta peptides derived from APP can assemble into soluble oligomers, fibrils, and extracellular deposits, while APP itself and its other cleavage products continue to be investigated for functions independent of amyloid plaque formation. An Amyloid Precursor Protein Antibody can therefore support research into APP expression and processing as well as broader studies of neuronal and neurodegenerative biology.
An APP Antibody directed against the amyloid beta-containing region of human APP provides a reagent for studying APP-associated protein species. This antibody was generated against a human APP-derived sequence encompassing the amyloid beta region and recognizes human, mouse, and rat samples. NSJ Bioreagents offers this antibody for research into APP expression, processing, and related neuroscience biology.
For a monoclonal targeting the same protein family and amyloid-associated region, see our Amyloid Beta Antibody APP/3345 / Beta Amyloid Antibody page.
The stated application concentrations are suggested starting amounts. Titration of the APP Antibody / Amyloid Precursor Protein Antibody may be required due to differences in protocols and secondary/substrate sensitivity.
An amino acid sequence from the C-terminus of human Amyloid Precursor Protein (DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA) was used as the immunogen for this APP Antibody.
After reconstitution, the APP Antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
APP antibody, Amyloid precursor protein antibody, Amyloid beta precursor protein antibody, ABPP antibody, PreA4 antibody, Protease nexin-II antibody, PN-II antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.